NexGel, Inc (NXGL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NXGL SEC filings page.
NexGel, Inc (NXGL) reported $11.4M in revenue for fiscal year 2025, up 31.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is scaling and margins are improving, but operating costs still prevent self-funded growth and leave the balance sheet less liquid.
Gross profit increased from$2.7M in FY2024 to$4.5M in FY2025, creating more contribution from each sales dollar. Net loss narrowed only from$3.3M to$3.0M , showing that the added gross profit has not yet translated into comparable earnings because overhead absorbs much of it.
Gross margin rose from
Short-term balance-sheet flexibility weakened as the current ratio fell from 2.1x in FY2024 to 1.5x in FY2025. Operating cash flow remained negative at
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of NexGel, Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
NexGel, Inc held $317K in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $1.3M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and NexGel, Inc scores 12/100 among other emerging companies.
NexGel, Inc had 8M shares outstanding at the end of fiscal year 2025, against 8M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and NexGel, Inc scores 39/100 among other emerging companies.
NexGel, Inc spent $2K on research and development in fiscal year 2025, which was 0.0% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and NexGel, Inc scores 2/100 among other emerging companies.
NexGel, Inc reported revenue of $11.4M in fiscal year 2025, against $8.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and NexGel, Inc scores 83/100 among other emerging companies.
NexGel, Inc's operations used $1.3M of cash in fiscal year 2025, against $3.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and NexGel, Inc scores 74/100 among other emerging companies.
NexGel, Inc's cash, cash equivalents and investments came to $317K at the end of fiscal year 2025, against $5.6M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and NexGel, Inc scores 11/100 among other emerging companies.
NexGel, Inc scores -2.46, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.5M) relative to total liabilities ($5.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
NexGel, Inc passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
NexGel, Inc reported a net loss of $3.0M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
NexGel, Inc reported an operating loss of $3.4M against $34K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
NexGel, Inc generated $3.7M in revenue in Q2 2026. This represents an increase of 27.8% from the same quarter a year earlier. Against the prior quarter it is up 39.1%.
NexGel, Inc's EBITDA was -$1.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 219.6% from the same quarter a year earlier. Against the prior quarter it is down 95.3%.
NexGel, Inc reported -$3.6M in net income in Q2 2026. This represents a decrease of 446.6% from the same quarter a year earlier. Against the prior quarter it is down 292.1%.
NexGel, Inc earned -$0.40 per diluted share (EPS) in Q2 2026. This represents a decrease of 344.4% from the same quarter a year earlier. Against the prior quarter it is down 263.6%.
Cash & Balance Sheet
NexGel, Inc held $1.7M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
NexGel, Inc's gross margin was 30.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 13.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.9 percentage points.
NexGel, Inc's operating margin was -68.0% in Q2 2026, reflecting core business profitability. This is down 45.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 31.8 percentage points.
NexGel, Inc's net profit margin was -98.6% in Q2 2026, showing the share of revenue converted to profit. This is down 75.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 63.6 percentage points.
NexGel, Inc's ROE was -73.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 59.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 50.2 percentage points.
Capital Allocation
NexGel, Inc invested $20K in research and development in Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
NXGL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7M+27.8% | $2.6M-5.6% | $2.8M-8.1% | $2.9M-0.2% | $2.9M+100.3% | $2.8M+121.6% | $3.0M+181.4% | $2.9M+140.8% |
| Cost of Revenue | $2.6M+58.5% | $1.6M-1.8% | $2.0M+3.9% | $1.7M-5.3% | $1.6M+41.8% | $1.6M+46.3% | $1.9M+62.7% | $1.8M+103.5% |
| Gross Profit | $1.1M-11.8% | $1.1M-10.7% | $820K-28.1% | $1.2M+7.6% | $1.3M+329.4% | $1.2M+642.5% | $1.1M+1395.5% | $1.2M+235.8% |
| R&D Expenses | $20K | N/A | N/A | $7K | N/A | $1K-50.0% | N/A | N/A |
| SG&A Expenses | $3.6M+89.8% | $2.0M+2.8% | $2.0M+3.0% | $2.0M+0.9% | $1.9M+49.0% | $2.0M+90.9% | $2.0M+77.0% | $1.9M+104.5% |
| Operating Income | -$2.5M-293.9% | -$958K-23.3% | -$1.2M-44.4% | -$725K+8.0% | -$636K+39.7% | -$777K+10.8% | -$841K+31.1% | -$788K-28.8% |
| EBITDA | -$1.7M-219.6% | -$859K-29.6% | -$1.1M-50.3% | -$612K-1.3% | -$525K+46.0% | -$663K+18.0% | -$733K+33.2% | -$604K-4.7% |
| Interest Expense | $2.2M+10500.0% | $42K+100.0% | N/A | N/A | $21K-30.0% | $21K+40.0% | $16K+700.0% | $20K+566.7% |
| Net Income | -$3.6M-446.6% | -$927K-30.2% | -$970K-14.1% | -$653K+5.8% | -$665K+24.9% | -$712K+16.5% | -$850K+22.6% | -$693K-26.0% |
| EPS (Basic) | -$0.40-344.4% | -$0.11-22.2% | -$0.12-9.1% | -$0.08+27.3% | -$0.09+35.7% | -$0.09+35.7% | -$0.11+45.0% | -$0.11-10.0% |
| EPS (Diluted) | -$0.40-344.4% | -$0.11-22.2% | -$0.12-9.1% | -$0.08+27.3% | -$0.09+35.7% | -$0.09+35.7% | -$0.11+45.0% | -$0.11-10.0% |
| Diluted Shares (Avg) | 9M+17.8% | 8M+7.3% | N/A | 8M+21.3% | 8M+22.4% | 8M+27.8% | N/A | 7M+15.0% |
Not reported in any period shown, so not listed: Income Tax.
NXGL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.4M+172.3% | $11.6M+11.1% | $10.5M-4.8% | $11.6M+9.9% | $9.7M-0.7% | $10.4M+0.5% | $11.0M+10.3% | $10.6M+6.3% |
| Current Assets | $6.2M+48.2% | $5.6M+18.9% | $4.3M-15.2% | $5.6M+21.5% | $4.2M+16.0% | $4.7M-2.5% | $5.1M+1.2% | $4.6M-21.6% |
| Cash & Equivalents | $1.7M+135.3% | $2.1M+78.0% | $317K-82.5% | $938K-11.4% | $725K-32.2% | $1.2M-50.7% | $1.8M-33.1% | $1.1M-67.6% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $2.3M+26.5% | $2.3M+22.6% | $2.1M+20.6% | $2.0M+13.6% | $1.8M+25.9% | $1.8M+34.8% | $1.8M+32.8% | $1.8M+63.1% |
| Accounts Receivable | $1.1M+43.3% | $662K-28.5% | $673K-27.9% | $839K-6.2% | $753K+24.5% | $926K+25.3% | $933K+47.4% | $894K-22.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $1.1M0.0% | $1.1M0.0% | $1.1M0.0% | $1.1M+0.4% | $1.1M0.0% | $1.1M0.0% | $1.1M0.0% | $1.1M+261.4% |
| Total Liabilities | $21.0M+350.6% | $7.1M+46.1% | $5.6M+13.6% | $6.0M+8.2% | $4.7M-11.3% | $4.9M-6.0% | $4.9M+2.4% | $5.6M+51.3% |
| Current Liabilities | $14.4M+502.7% | $3.3M+31.6% | $3.0M+19.7% | $3.3M+8.5% | $2.4M-9.0% | $2.5M+1.4% | $2.5M-3.1% | $3.0M+85.5% |
| Non-Current Liabilities | $6.5M+189.4% | $3.8M+61.8% | $2.6M+7.4% | $2.7M+7.8% | $2.3M-13.6% | $2.4M-12.9% | $2.4M+8.6% | $2.5M+23.9% |
| Long-Term Debt | N/A | $563K-15.0% | $588K-14.2% | $614K-13.4% | $638K-12.8% | $662K-11.7% | $685K+15.5% | $709K+154.1% |
| Total Equity | $4.9M+6.0% | $4.0M-23.3% | $4.5M-22.5% | $5.2M+10.6% | $4.7M+12.1% | $5.2M+8.8% | $5.8M+22.5% | $4.7M-17.7% |
| Retained Earnings | -$25.6M-31.9% | -$21.9M-17.2% | -$21.0M-16.7% | -$20.0M-16.8% | -$19.4M-17.7% | -$18.7M-20.2% | -$18.0M-22.3% | -$17.1M-25.9% |
NXGL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.2M-439.8% | -$504K-26.0% | $281K+132.7% | -$785K+35.4% | -$407K+41.9% | -$400K+63.4% | -$859K-46.3% | -$1.2M-68.2% |
| Depreciation & Amortization | $827K+645.0% | $99K-13.2% | $112K+3.7% | $113K-38.6% | $111K+35.4% | $114K+83.9% | $108K-12.2% | $184K+425.7% |
| Stock-Based Compensation | N/A | $143K-13.9% | N/A | N/A | N/A | $166K+207.4% | N/A | N/A |
| Capital Expenditures | N/A | $9K | $40K-42.0% | $8K-38.5% | N/A | N/A | $69K-18.8% | $13K-96.4% |
| Free Cash Flow | N/A | -$513K | $241K+126.0% | -$793K+35.5% | N/A | N/A | -$928K-38.1% | -$1.2M-13.7% |
| Investing Cash Flow | -$6.6M | -$9K | -$40K+36.5% | -$8K0.0% | N/A | N/A | -$63K+76.9% | -$8K-103.8% |
| Financing Cash Flow | $8.4M+20997.5% | $1.6M+833.5% | -$1.0M-162.3% | $1.9M+58.6% | -$40K+37.5% | -$215K-123.1% | $1.7M+468.0% | $1.2M+1279.5% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
NXGL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.1%-13.5pp | 40.0%-2.3pp | 29.3%-8.2pp | 42.4%+3.1pp | 43.6%+23.3pp | 42.3%+29.7pp | 37.5%+45.6pp | 39.3%+11.1pp |
| Operating Margin | -68.0%-45.9pp | -36.1%-8.5pp | -43.4%-15.7pp | -24.7%+2.1pp | -22.1%+51.1pp | -27.7%+41.1pp | -27.7% | -26.8%+23.3pp |
| Net Margin | -98.6%-75.6pp | -35.0%-9.6pp | -34.7%-6.7pp | -22.3%+1.3pp | -23.1%+38.4pp | -25.4%+42.0pp | -27.9% | -23.6%+21.5pp |
| Return on Equity | -73.5%-59.2pp | -23.2%-9.5pp | -21.7%-7.0pp | -12.6%+2.2pp | -14.2%+7.0pp | -13.7%+4.2pp | -14.8%+8.6pp | -14.8%-5.1pp |
| Return on Assets | -13.7%-6.9pp | -8.0%-1.2pp | -9.3%-1.5pp | -5.6%+0.9pp | -6.9%+2.2pp | -6.8%+1.4pp | -7.7%+3.3pp | -6.6%-1.0pp |
| Current Ratio | 0.43-1.3x | 1.70-0.2x | 1.47-0.6x | 1.69+0.2x | 1.74+0.4x | 1.88-0.1x | 2.07+0.1x | 1.51-2.1x |
| Debt-to-Equity | 4.24+4.1x | 0.140.0x | 0.130.0x | 0.120.0x | 0.140.0x | 0.130.0x | 0.120.0x | 0.15+0.1x |
| Asset Turnover | 0.14-0.2x | 0.230.0x | 0.270.0x | 0.250.0x | 0.30+0.1x | 0.27+0.1x | 0.28+0.2x | 0.28+0.2x |
| FCF Margin | N/A | -19.4% | 8.6%+39.1pp | -27.0%+14.8pp | N/A | N/A | -30.5%+31.7pp | -41.8%+46.7pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| NexGel, Inc NXGL | FY2025 | $11.4M | -$3.0M | -26.3% | $1.5M | 37/100 |
| Harvard Bioscience Inc HBIO | FY2025 | $86.5M | -$56.7M | -65.5% | $38.7M | 38/100 |
| Retractable Technologies, Inc RVP | FY2025 | $38.3M | -$12.6M | -32.8% | $20.7M | 24/100 |
| Bionano Genomics, Inc. BNGO | FY2025 | $28.5M | -$26.4M | -92.6% | $17.2M | 56/100 |
| Precision Optics Corporation, Inc. POCI | FY2026 | $31.5M | -$3.6M | -11.5% | $49.6M | 51/100 |
| Meihua International Medical Technologies Co., Ltd. MHUA | FY2025 | $61.8M | $6.8M | 11.0% | $425.4M | 59/100 |
Where NexGel, Inc Ranks
Frequently Asked Questions
What is NexGel, Inc's annual revenue?
NexGel, Inc (NXGL) reported $11.4M in total revenue for fiscal year 2025. This represents a 31.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is NexGel, Inc's revenue growing?
NexGel, Inc (NXGL) revenue grew by 31.5% year-over-year, from $8.7M to $11.4M in fiscal year 2025.
Is NexGel, Inc profitable?
No, NexGel, Inc (NXGL) reported a net income of -$3.0M in fiscal year 2025, with a net profit margin of -26.3%.
What is NexGel, Inc's EBITDA?
NexGel, Inc (NXGL) had EBITDA of -$2.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does NexGel, Inc have?
As of fiscal year 2025, NexGel, Inc (NXGL) had $317K in cash and equivalents against $588K in long-term debt.
What is NexGel, Inc's gross margin?
NexGel, Inc (NXGL) had a gross margin of 39.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is NexGel, Inc's operating margin?
NexGel, Inc (NXGL) had an operating margin of -29.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is NexGel, Inc's net profit margin?
NexGel, Inc (NXGL) had a net profit margin of -26.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is NexGel, Inc's return on equity (ROE)?
NexGel, Inc (NXGL) has a return on equity of -67.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is NexGel, Inc's free cash flow?
NexGel, Inc (NXGL) recorded an outflow of $1.4M in free cash flow during fiscal year 2025. This represents a 68.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is NexGel, Inc's operating cash flow?
NexGel, Inc (NXGL) recorded an outflow of $1.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are NexGel, Inc's total assets?
NexGel, Inc (NXGL) had $10.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are NexGel, Inc's capital expenditures?
NexGel, Inc (NXGL) invested $68K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does NexGel, Inc spend on research and development?
NexGel, Inc (NXGL) invested $2K in research and development during fiscal year 2025.
What is NexGel, Inc's current ratio?
NexGel, Inc (NXGL) had a current ratio of 1.47 as of fiscal year 2025, which is considered adequate.
What is NexGel, Inc's debt-to-equity ratio?
NexGel, Inc (NXGL) had a debt-to-equity ratio of 0.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is NexGel, Inc's return on assets (ROA)?
NexGel, Inc (NXGL) had a return on assets of -28.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is NexGel, Inc's P/E ratio?
NexGel, Inc (NXGL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.5M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is NexGel, Inc's price-to-sales ratio?
NexGel, Inc (NXGL) trades at 0.1x sales, its market capitalization divided by revenue of $12.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.5M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does NexGel, Inc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, NexGel, Inc (NXGL) held $317K in cash, cash equivalents and investments, and reported an operating cash outflow of $1.3M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is NexGel, Inc's Altman Z-Score?
NexGel, Inc (NXGL) has an Altman Z-Score of -2.46, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is NexGel, Inc's Piotroski F-Score?
NexGel, Inc (NXGL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NexGel, Inc's earnings high quality?
NexGel, Inc (NXGL) reported a net loss of $3.0M while operations used $1.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can NexGel, Inc cover its interest payments?
NexGel, Inc (NXGL) reported an operating loss of $3.4M against $34K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is NexGel, Inc?
NexGel, Inc (NXGL) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.